Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius Müller

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Journal of Medicinal Chemistry|February 18, 2025
An <sup>211</sup>At-labeled Tetrazine for Pretargeted TherapyMatthias M Herth, Lars Hvass, Christian B M Poulie, et al.
Blood|July 8, 2026
USP22 is a novel vulnerability regulating MEIS1 protein abundance and gene transcription in KMT2Ar acute leukemiaSarah Bröchtel, Constanze Schneider, Marius Müller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 29, 2024
Development and Preclinical Evaluation of [<sup>211</sup>At]PSAt-3-Ga: An Inhibitor for Targeted α-Therapy of Prostate CancerMohamed El Fakiri, Nawal Ayada, Marius Müller, et al.
Pathogens & Immunity|February 6, 2025
The TB27 Transcriptomic Model for Predicting <i>Mycobacterium tuberculosis</i> Culture ConversionMaja Reimann, Korkut Avsar, Andrew R DiNardo, et al.
The European Respiratory Journal|February 12, 2021
Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic modelJan Heyckendorf, Sebastian Marwitz, Maja Reimann, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Journal of Medicinal Chemistry|February 18, 2025
An <sup>211</sup>At-labeled Tetrazine for Pretargeted TherapyMatthias M Herth, Lars Hvass, Christian B M Poulie, et al.
Blood|July 8, 2026
USP22 is a novel vulnerability regulating MEIS1 protein abundance and gene transcription in KMT2Ar acute leukemiaSarah Bröchtel, Constanze Schneider, Marius Müller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 29, 2024
Development and Preclinical Evaluation of [<sup>211</sup>At]PSAt-3-Ga: An Inhibitor for Targeted α-Therapy of Prostate CancerMohamed El Fakiri, Nawal Ayada, Marius Müller, et al.
Pathogens & Immunity|February 6, 2025
The TB27 Transcriptomic Model for Predicting <i>Mycobacterium tuberculosis</i> Culture ConversionMaja Reimann, Korkut Avsar, Andrew R DiNardo, et al.
The European Respiratory Journal|February 12, 2021
Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic modelJan Heyckendorf, Sebastian Marwitz, Maja Reimann, et al.
Pageof 4